S
Shelby Sullivan
Researcher at University of Colorado Denver
Publications - 82
Citations - 5321
Shelby Sullivan is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Weight loss & Randomized controlled trial. The author has an hindex of 24, co-authored 74 publications receiving 4073 citations. Previous affiliations of Shelby Sullivan include Washington University in St. Louis & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic and Clinical Implications
TL;DR: It is not clear whether NAFLD causes metabolic dysfunction or whether metabolic dysfunction is responsible for IHTG accumulation, or possibly both, but it is likely that abnormalities in fatty acid metabolism are key factors involved in the development of insulin resistance, dyslipidemia, and other cardiometabolic risk factors associated withNAFLD.
Journal ArticleDOI
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen,Manal F. Abdelmalek,Shelby Sullivan,Kristen J. Nadeau,Melanie Green,Carlos Roncal,Takahiko Nakagawa,Masanari Kuwabara,Yuka Sato,Duk Hee Kang,Dean R. Tolan,Laura G. Sánchez-Lozada,Hugo R. Rosen,Miguel A. Lanaspa,Anna Mae Diehl,Richard J. Johnson +15 more
TL;DR: Small, more definitive trials are suggested to determine if lowering sugar/HFCS intake, and/or blocking uric acid generation, may help reduce NAFLD and its downstream complications of cirrhosis and chronic liver disease.
Journal ArticleDOI
ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies
Barham K. Abu Dayyeh,Nitin Kumar,Steven A. Edmundowicz,Sreenivasa S. Jonnalagadda,Michael C. Larsen,Shelby Sullivan,Christopher C. Thompson,Subhas Banerjee +7 more
TL;DR: The task force recognizes the Orbera IGB for meeting the PIVI criteria for the management of obesity and recognizes the EndoBarrier duodenal-jejunal bypass sleeve (DJBS) for failing to meet the PivI thresholds.
Journal ArticleDOI
Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.
Shelby Sullivan,Erik P. Kirk,Erik P. Kirk,Bettina Mittendorfer,Bruce W. Patterson,Samuel Klein +5 more
TL;DR: Following the Department of Health and Human Services recommended physical activity guidelines has small but beneficial effects on IHTG content, but does not improve hepatic lipoprotein kinetics in obese persons with NAFLD.
Journal ArticleDOI
The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity
Jaime Ponce,George Woodman,James M. Swain,Erik B. Wilson,Wayne J. English,Sayeed Ikramuddin,Eric S. Bour,Steven A. Edmundowicz,Brad Snyder,Flavia Soto,Shelby Sullivan,Richard G. Holcomb,John W. Lehmann +12 more
TL;DR: The DBS was significantly more effective than diet and exercise in causing weight loss with a low adverse event profile and accommodation symptoms abated rapidly with support and medication.